enow.com Web Search

Search results

1. Results from the WOW.Com Content Network

2. New prostate cancer imaging shows ‘extremely encouraging ...

   www.aol.com/prostate-cancer-imaging-shows...

   Prostate cancer imaging developed by university researchers has shown “extremely encouraging” results in its first clinical trials. A team at Heriot-Watt University, Edinburgh, leading the ...

3. STAMPEDE (clinical trial) - Wikipedia

   en.wikipedia.org/wiki/STAMPEDE_(clinical_trial)

   The trial investigates new approaches for men with metastatic and locally advanced prostate cancer. [1] 117 hospitals in the UK and Switzerland are involved with over 10,000 men are expected to take part in the trial. [2] The men are randomly assigned to one of a number of "arms". The primary outcome by which the arms were judged is overall ...

4. Janux Therapeutics surges on upbeat trial data for prostate ...

   www.aol.com/news/janux-therapeutics-surges-trial...

   TD Cowen analyst Marc Frahm said the data establishes that Janux's prostate cancer therapy, JANX007, has multi-billion-dollar potential. Janux Therapeutics surges on upbeat trial data for prostate ...

5. New treatment ‘increases chance of survival’ for prostate ...

   www.aol.com/treatment-increases-chance-survival...

   A total of 150 people took part in the trial. ... prostate cancer have a greater chance of survival if treated with a targeted cancer drug in addition to chemotherapy, according to a new study. ...

6. Scandinavian Prostate Cancer Group - Wikipedia

   en.wikipedia.org/wiki/Scandinavian_Prostate...

   The Scandinavian Prostate Cancer Group (SPCG) is a group of scientific researchers who have conducted a series of clinical trials of treatments for prostate cancer. [ 1 ] [ 2 ] The group was founded in 1981 and the first study, SPCG-1, began in 1984.

7. Prostate Adenocarcinoma: TransCutaneous Hormones - Wikipedia

   en.wikipedia.org/wiki/Prostate_Adenocarcinoma:...

   The Prostate Adenocarcinoma: TransCutaneous Hormones (PATCH) study is a large randomized controlled trial in the United Kingdom of high-dose transdermal estradiol patches versus gonadotropin-releasing hormone agonist therapy in the treatment of prostate cancer in men.